| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 6Z3QHB00LB |
| InChI Key | ADGGYDAFIHSYFI-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C17H20F3N7O2 |
| Molecular Weight | 411.39 |
| AlogP | 1.21 |
| Hydrogen Bond Acceptor | 9.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 102.52 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 29.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
Atypical protein kinase group
Atypical protein kinase PIKK family
Atypical protein kinase FRAP subfamily
|
- | 89-205 | 12 | 62-62 | - | |
|
Enzyme
Kinase
Protein Kinase
Atypical protein kinase group
Atypical protein kinase PIKK family
|
- | 89-205 | 12 | 62-62 | - | |
|
Enzyme
Transferase
|
- | 33-136 | 11 | 17-17 | - | |
|
Enzyme
|
- | 33-136 | 11 | 62-62 | - | |
|
Other cytosolic protein
|
- | 139 | - | - | - | |
|
Unclassified protein
|
- | 139 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 2 | D008228 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1225037-39-7 |
| ChEMBL | CHEMBL4084907 |
| DrugBank | DB14846 |
| FDA SRS | 6Z3QHB00LB |
| Guide to Pharmacology | 8383 |
| PDB | A3W |
| PubChem | 58507717 |
| SureChEMBL | SCHEMBL1309049 |
| ZINC | ZINC000068203488 |